• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在酪氨酸激酶受体基因Etk2/tyro3中鉴定可变外显子,包括一个新外显子,这些可变外显子解释了5' cDNA序列中的差异。

Identification of alternative exons, including a novel exon, in the tyrosine kinase receptor gene Etk2/tyro3 that explain differences in 5' cDNA sequences.

作者信息

Biesecker L G, Giannola D M, Emerson S G

机构信息

National Institutes of Health, National Center for Human Genome Research, Bethesda, Maryland 20892, USA.

出版信息

Oncogene. 1995 Jun 1;10(11):2239-42.

PMID:7784069
Abstract

Protein tyrosine kinase transmembrane receptors trigger signal transduction cascades upon ligand binding, resulting in cellular proliferation, differentiation, differentiation inhibition or apoptosis depending upon the cell target. The ETK2/TYRO3 receptor is a tyrosine kinase expressed in embryonic stem cells, brain and testis that has recently been cloned by several groups. Analysis of cDNA clones isolated from several tissues shows 2 isoforms of the Etk2/tyro3 gene product that result from usage of alternative exons near the 5' end of the gene. In addition, our data suggest that a third alternative exon is positioned between these two alternative exons. This novel exon encodes yet another isoform that predicts a unique amino-terminal protein sequence. The alternative exons (exons 2A, 2B and 2C), predict three isoforms with different initiation codons, signal sequences and lengths. The existence of these multiple isoforms may be important for protein processing, translocation, or function.

摘要

蛋白质酪氨酸激酶跨膜受体在配体结合后触发信号转导级联反应,根据细胞靶点的不同,导致细胞增殖、分化、分化抑制或凋亡。ETK2/TYRO3受体是一种在胚胎干细胞、脑和睾丸中表达的酪氨酸激酶,最近已被多个研究小组克隆。对从多个组织中分离的cDNA克隆的分析表明,Etk2/tyro3基因产物有两种异构体,这是由该基因5'端附近可变外显子的使用导致的。此外,我们的数据表明,第三个可变外显子位于这两个可变外显子之间。这个新的外显子编码另一种异构体,预测一个独特的氨基末端蛋白质序列。可变外显子(外显子2A、2B和2C)预测了三种具有不同起始密码子、信号序列和长度的异构体。这些多种异构体的存在可能对蛋白质加工、转运或功能很重要。

相似文献

1
Identification of alternative exons, including a novel exon, in the tyrosine kinase receptor gene Etk2/tyro3 that explain differences in 5' cDNA sequences.在酪氨酸激酶受体基因Etk2/tyro3中鉴定可变外显子,包括一个新外显子,这些可变外显子解释了5' cDNA序列中的差异。
Oncogene. 1995 Jun 1;10(11):2239-42.
2
Molecular cloning of cytochrome P450 aromatase complementary deoxyribonucleic acid from periimplantation porcine and equine blastocysts identifies multiple novel 5'-untranslated exons expressed in embryos, endometrium, and placenta.从着床前后的猪和马囊胚中克隆细胞色素P450芳香化酶互补脱氧核糖核酸,鉴定出在胚胎、子宫内膜和胎盘中表达的多个新的5'-非翻译外显子。
Endocrinology. 1996 Apr;137(4):1457-67. doi: 10.1210/endo.137.4.8625924.
3
Novel splicing variants of recepteur d'origine nantais (RON) tyrosine kinase involving exons 15-19 in lung cancer.肺癌中涉及第15至19外显子的源自南特的受体(RON)酪氨酸激酶的新型剪接变体。
Lung Cancer. 2016 Feb;92:41-6. doi: 10.1016/j.lungcan.2015.12.002. Epub 2015 Dec 12.
4
Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor.新型C类G蛋白偶联受体GPRC6A的分子克隆、表达及序列分析
Gene. 2004 Jun 23;335:37-46. doi: 10.1016/j.gene.2004.03.003.
5
Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts.
Oncogene. 1993 Nov;8(11):2931-7.
6
Identification of novel mRNA isoforms for human DNA polymerase beta.人类DNA聚合酶β新型mRNA亚型的鉴定
DNA Cell Biol. 1996 Aug;15(8):653-9. doi: 10.1089/dna.1996.15.653.
7
Organization of the human PTK7 gene encoding a receptor protein tyrosine kinase-like molecule and alternative splicing of its mRNA.编码一种受体蛋白酪氨酸激酶样分子的人类PTK7基因的组织及其mRNA的可变剪接。
Biochim Biophys Acta. 2002 Dec 12;1579(2-3):153-63. doi: 10.1016/s0167-4781(02)00536-5.
8
Two distinct protein isoforms are encoded by ntk, a csk-related tyrosine protein kinase gene.ntk(一种与csk相关的酪氨酸蛋白激酶基因)编码两种不同的蛋白质异构体。
Oncogene. 1994 Dec;9(12):3437-48.
9
Alternatively spliced human type 1 angiotensin II receptor mRNAs are translated at different efficiencies and encode two receptor isoforms.选择性剪接的人1型血管紧张素II受体mRNA以不同效率进行翻译,并编码两种受体亚型。
Mol Endocrinol. 1995 Sep;9(9):1250-62. doi: 10.1210/mend.9.9.7491117.
10
Multiple alternatively spliced transcripts of the receptor tyrosine kinase MuSK are expressed in muscle.受体酪氨酸激酶MuSK的多个可变剪接转录本在肌肉中表达。
Gene. 2005 Nov 7;360(2):83-91. doi: 10.1016/j.gene.2005.07.009. Epub 2005 Sep 16.

引用本文的文献

1
TYRO3: A potential therapeutic target in cancer.TYRO3:癌症治疗的潜在靶点。
Exp Biol Med (Maywood). 2019 Feb;244(2):83-99. doi: 10.1177/1535370219828195. Epub 2019 Feb 2.
2
The Emerging Role of TYRO3 as a Therapeutic Target in Cancer.TYRO3作为癌症治疗靶点的新作用
Cancers (Basel). 2018 Nov 29;10(12):474. doi: 10.3390/cancers10120474.
3
The Dual Role of TAM Receptors in Autoimmune Diseases and Cancer: An Overview.TAM受体在自身免疫性疾病和癌症中的双重作用:综述
Cells. 2018 Oct 12;7(10):166. doi: 10.3390/cells7100166.
4
The tyrosine kinase receptor Tyro3 enhances lifespan and neuropeptide Y (Npy) neuron survival in the mouse anorexia () mutation.酪氨酸激酶受体 Tyro3 增强了 () 突变小鼠的寿命和神经肽 Y (Npy) 神经元的存活。
Dis Model Mech. 2017 May 1;10(5):581-595. doi: 10.1242/dmm.027433. Epub 2017 Jan 12.
5
TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.TAM受体酪氨酸激酶:生物学功能、信号传导及在人类癌症中的潜在治疗靶点
Adv Cancer Res. 2008;100:35-83. doi: 10.1016/S0065-230X(08)00002-X.